Philips & Nuance Team Up To Bring AI In Radiology Reporting
Zacks Investment Research | Nov 16, 2017 08:41PM ET
Koninklijke Philips N.V. (NYSE:PHG) recently announced that it has decided to team up with Nuance Communications (NASDAQ:NUAN) to bring artificial intelligence-based (AI) image interpretation and reporting capabilities to radiologists. The partnership will leverage Philips’ Illumeo with adaptive intelligence, and Nuance’s PowerScribe 360, to reduce discrepancies, and improve radiology reporting, standardization as well as accuracy.
Touted as one of the modern imaging and informatics technology, Illumeo is powered with adaptive intelligence. It supplements the work of a radiologist by integrating contextual awareness capabilities with advanced data analytics. On the other hand, Nuance PowerScribe 360, a real-time radiology reporting platform, facilitates rapid generation of high-quality actionable reports.
The integration of Philips Illumeo and Nuance PowerScribe 360 will enable radiologists to access a variety of tools at the point-of-care. These include tools for risk stratification, faster turnaround times as well as greater report accuracy and structure. The collaboration will enable radiologists to access AI-driven solutions and practical applications, including the integration of ACR guidelines, which would save time as well as effort along with improving report quality and patient outcomes.
Healthcare Market Losing Momentum
Philips has broadened its presence in the healthcare markets in recent quarters and expects this segment to be a long-term growth driver. However, the company’s near-term profitability is likely to be hurt by sluggish growth prospects of the healthcare market on a global scale. For instance, the company expects the United States to witness low single digit growth in the healthcare industry, in light of uncertainties like slowing government spending and events surrounding the ACA (Affordable Care Act) legislation. Also, factors like anti-corruption initiatives, slow GDP growth and centralized tendering remain country-specific risks for China are likely to dampen the prospects of the healthcare industry, thwarting the company’ growth.
Moreover, as this Zacks Rank #5 (Strong Sell) company has a geographic presence in more than 80 countries, it is exposed to a number of regional and local regulatory rules in sensitive areas like healthcare. The company believes such stringent rules expose it to difficulties in obtaining clearances or approvals for new products, which in turn, may lead to unfavorable performance. Further, the industry in which Philips operates is highly dynamic, which indicates that failure to accelerate the company’s innovation-to-market processes may lead to materially adverse effects on its financial condition as well as operating results.
The stock has returned 6% in the last three months, underperforming the Original post
Get The News You Want
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.